The merger of two pioneers of psychedelic medicines has completed with the creation of AtaiBeckley, a company with a pipeline ...

Biohaven's troriluzole candidate for spinocerebellar ataxia (SCA) has been turned down by the FDA, causing shares in the ...

"The UK's inability to retain economic benefits of its R&D is a fatal flaw to any growth strategy," according to the document ...

The financial results show top-line sales growth in the first nine months of the year of 12% to DKK 230 billion ($35.4 ...

This article aims to share how to build an effective healthcare content strategy that boosts online patient engagement and ...

Hard on the heels of the disclosure that Merck KGaA is talking to SpringWorks about a possible takeover, a new FDA approval could have sweetened the deal. Stamford, Connecticut-based SpringWorks' ...

Lyon, France-based late-stage clinical biotech MaaT Pharma has presented new preclinical data for MaaT034 at the American Association for Cancer Research (AACR) annual meeting 2025 in Chicago, US – ...

CSL Behring has added another major European market to the list of those providing reimbursement coverage of its haemophilia B gene therapy Hemgenix, after agreeing an access deal in Germany. The ...

US biotech NeOnc Technologies has applied to list on the Nasdaq as it advances a portfolio of drugs to treat diseases affecting the central nervous system. The Westlake Village, California-based ...

Bristol-Myers Squibb has become the latest drugmaker in the US to file a legal challenge to a block on a drug rebate model opposed by a Health and Human Services (HHS) department. Specifically, BMS is ...

In a landmark procedure performed at Massachusetts General Hospital (MGH) on 25 th January 2025, a 66-year-old man with end-stage renal disease (ESRD) received a genetically modified pig kidney, ...

Shares in Metsera shot up nearly 20% to more than $72 after news of the renewed bidding war emerged, raising its market ...